Product Images Duloxetine

Each capsule of Delyecelease contains 224mg of duloxetine hydrochloride, equivalent to 20mg of duloxetine USP. It is advised to not chew or crush the capsules and to check for tampering. There is a medication guide available for reference. The manufacturer is Camber Pharmaceuticals Inc. and the capsules are distributed in a pack of 60. Dosage and administration information should be consulted on the package insert. The remaining text is not legible.*

This is a description of a medication called Camber containing duloxetine hydrochloride. It comes in delayed-release capsules and each capsule has 33.7 mg of duloxetine hydrochloride, USP equivalent to 30 mg of duloxetine. The medication guide should be given to each patient. The usual dosage is stated in the package insert. Capsules should not be chewed or crushed, and kept out of reach of children. The manufacturing company is Camber Pharmaceuticals Inc. located in NJ, USA and manufactured by Hetero Labs Limited in Hyderabad, India. The contact number for the US is 1-866-495-1995.*

Each Camber Pharmaceuticals delayed-release capsule contains 67.3 mg of duloxetine hydrochloride, USP equivalent to 60 mg of duloxetine. The capsules should be kept at controlled room temperature and dispensed in a tightly closed container. They should not be chewed or crushed and are not suitable for children. More information about dosing and administration can be found in the medication guide. The product is manufactured in India, and there is contact information available for the manufacturer.*

Not available.*

The text describes a graph that compares the relapse in patients who were treated with a placebo and patients who were treated with Duloxetine. The x-axis represents the time from when the patient was randomized to the study till the point where the patient had a relapse while the y-axis represents the percentage of patients who experienced a relapse.*

The text is a graph showing the percentage improvement in pain from baseline for different treatments (Duloxetine 60mg BID, Duloxetine 60mg OD, Duloxetine 20mg OD, and Placebo). The X-axis shows the percent improvement in pain and the Y-axis shows the number of patients. The highest percentage of improvement is 100% with Duloxetine 60mg BID treatment.*

This document seems to be presenting data in the form of a table or chart outlining the percentage of patients improved along with the percentage of improvement in pain from baseline. However, without further context or information, it is difficult to determine the specifics of the data and its significance.*